{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:02:06Z","timestamp":1790870526341,"version":"4.1.0"},"reference-count":21,"publisher":"American Veterinary Medical Association (AVMA)","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["javma"],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer disease (AD) is the leading cause of dementia among older adults. Current AD treatment options are limited, and the absence of appropriate research animals has significantly hindered the development of new AD therapies. Canine cognitive decline (CCD) is a major determinant of morbidity in older animals, with alterations in blood biomarkers, neuropathology, physiology, and behavior comparable to those seen in humans diagnosed with dementia and AD.<\/jats:p>\n                  <jats:p>The one-health goal of achieving optimal health is supported by academics, researchers, and governments. Veterinarians\u2019 ability to identify patients in the early stages of CCD is crucial to the successful implementation of interventions that can improve the quality of life of affected dogs. Timely identification of CCD also opens opportunities for innovative interdisciplinary research that will contribute to a better understanding of the underlying mechanisms, early detection, and effective treatments for AD, ultimately benefiting human health as well.<\/jats:p>\n                  <jats:p>\n                    Until now, veterinary practitioners have played limited roles as interdisciplinary leaders in the One Health initiative to combat disease. The authors discuss how client-owned animals with spontaneous, naturally occurring CCD can play a significant role as disease-relevant surrogates for translational AD research. The proposed Dogs Overcoming Geriatric Memory and Aging (DOGMA) Study  to be conducted in veterinary practices will analyze the relationship between blood biomarkers and biometric behavior in mature and older dogs, with the aim of establishing benchmark CCD data. The DOGMA Study is addressed in the companion Currents in One Health by Hunter et al,\n                    <jats:italic>AJVR<\/jats:italic>\n                    , November 2023.\n                  <\/jats:p>","DOI":"10.2460\/javma.23.02.0095","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T11:14:32Z","timestamp":1695813272000},"page":"1597-1604","source":"Crossref","is-referenced-by-count":19,"title":["Canine cognitive decline and Alzheimer disease: clinical insights to solve a shared one-health problem"],"prefix":"10.2460","volume":"261","author":[{"given":"Joel","family":"Ehrenzweig","sequence":"first","affiliation":[{"name":"Veterinary Health Research Centers, Midlothian, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Hunter","sequence":"additional","affiliation":[{"name":"Veterinary Health Research Centers, Overland Park, KS"},{"name":"One Medicine Consulting, Olathe, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1272","reference":[{"issue":"5","key":"ref1","series-title":"J Clin Med","first-page":"1709","article-title":"Advances in neurodegenerative diseases","volume":"12","author":"Van Schependom J","year":"2023","unstructured":"Van Schependom J, D\u2019haeseleer M. Advances in neurodegenerative diseases. J Clin Med. 2023;12(5):1709. doi:10.3390\/jcm12051709"},{"key":"ref2","article-title":"Alzheimer\u2019s Association","author":"2020 Alzheimer\u2019s disease facts and figures","unstructured":"2020 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Association. Accessed February 6, 2023. https:\/\/www.alz.org\/media\/documents\/alzheimers-facts-and-figures_1.pdf"},{"key":"ref3","article-title":"WHO","author":"Global dementia: Alzheimer\u2019s disease and other dementias: 2020-2030","unstructured":"Global dementia: Alzheimer\u2019s disease and other dementias: 2020-2030. WHO. Accessed February 6, 2023. https:\/\/www.who.int\/publications\/i\/item\/global-dementia-alzheimer-s-disease-and-other-dementias-2020-2030"},{"issue":"1","key":"ref4","series-title":"Alzheimers Dement (N Y)","first-page":"e12114","article-title":"Translational animal models for Alzheimer\u2019s disease: an Alzheimer\u2019s Association Business Consortium Think Tank","volume":"6","author":"Vitek MP","year":"2021","unstructured":"Vitek MP, Araujo JA, Fossel M,  Translational animal models for Alzheimer\u2019s disease: an Alzheimer\u2019s Association Business Consortium Think Tank. Alzheimers Dement (N Y). 2021;6(1):e12114. doi:10.1002\/trc2.12114"},{"issue":"3","key":"ref5","series-title":"Alzheimers Dement","first-page":"280","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling RA","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA,  Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):280-292. doi:10.1016\/j.jalz.2011.03.003"},{"key":"ref6","series-title":"Front Vet Sci","first-page":"551895","article-title":"Novel diagnostic tools for identifying cognitive impairment in dogs: behavior, biomarkers, and pathology","volume":"7","author":"Vikartovska Z","year":"2021","unstructured":"Vikartovska Z, Farbakova J, Smolek T,  Novel diagnostic tools for identifying cognitive impairment in dogs: behavior, biomarkers, and pathology. Front Vet Sci. 2021;7:551895. doi:10.3389\/fvets.2020.551895"},{"key":"ref7","series-title":"Front Vet Sci","first-page":"958488","article-title":"Assessment of risk factors in dogs with presumptive advanced canine cognitive dysfunction","volume":"9","author":"MacQuiddy B","year":"2022","unstructured":"MacQuiddy B, Moreno JA, Kusick B, McGrath S. Assessment of risk factors in dogs with presumptive advanced canine cognitive dysfunction. Front Vet Sci. 2022;9:958488. doi:10.3389\/fvets.2022.958488"},{"key":"ref8","article-title":"Geriatric canine cognitive dysfunction\/dementia","author":"Schutt T","year":"2017","unstructured":"Schutt T, Blicher Thomsen B. Geriatric canine cognitive dysfunction\/dementia. In: Proceedings of the 42nd World Small Animal Veterinary Association Congress. World Small Animal Veterinary Association; 2017."},{"issue":"3","key":"ref9","series-title":"J Neural Transm (Vienna)","first-page":"327","article-title":"Comparison of clinical and neuropathological diagnoses of neurodegenerative diseases in two centres from the Brains for Dementia Research (BDR) cohort","volume":"126","author":"Selvackadunco S","year":"2019","unstructured":"Selvackadunco S, Langford K, Shah Z,  Comparison of clinical and neuropathological diagnoses of neurodegenerative diseases in two centres from the Brains for Dementia Research (BDR) cohort. J Neural Transm (Vienna). 2019;126(3):327-337. doi:10.1007\/s00702-018-01967-w"},{"issue":"2","key":"ref10","series-title":"Med Clin North Am","first-page":"263","article-title":"The Alzheimer\u2019s disease clinical spectrum: diagnosis and management","volume":"103","author":"Atri A","year":"2019","unstructured":"Atri A. The Alzheimer\u2019s disease clinical spectrum: diagnosis and management. Med Clin North Am. 2019;103(2):263-293. doi:10.1016\/j.mcna.2018.10.009"},{"issue":"1","key":"ref11","series-title":"Neurotherapeutics","first-page":"173","article-title":"Neuropathology of Alzheimer\u2019s disease","volume":"19","author":"Trejo-Lopez JA","year":"2022","unstructured":"Trejo-Lopez JA, Yachnis AT, Prokop S. Neuropathology of Alzheimer\u2019s disease. Neurotherapeutics. 2022;19(1):173-185. doi:10.1007\/s13311-021-01146-y"},{"issue":"3","key":"ref12","series-title":"Vet J","first-page":"331","article-title":"The canine cognitive dysfunction rating scale (CCDR): a data-driven and ecologically relevant assessment tool","volume":"188","author":"Salvin HE","year":"2011","unstructured":"Salvin HE, McGreevy PD, Sachdev PS, Valenzuela MJ. The canine cognitive dysfunction rating scale (CCDR): a data-driven and ecologically relevant assessment tool. Vet J. 2011;188(3):331-336."},{"key":"ref13","series-title":"Appl Anim Behav Sci","first-page":"138","article-title":"Assessment of severity and progression of canine cognitive dysfunction syndrome using the CAnine DEmentia Scale (CADES)","volume":"171","author":"Madari A","year":"2015","unstructured":"Madari A, Farbakova J, Katina S,  Assessment of severity and progression of canine cognitive dysfunction syndrome using the CAnine DEmentia Scale (CADES). Appl Anim Behav Sci. 2015;171:138-145. doi:10.1016\/j.applanim.2015.08.034"},{"issue":"24","key":"ref14","series-title":"Animals (Basel)","first-page":"3538","article-title":"Evaluation of two practical tools to assess cognitive impairment in aged dogs","volume":"12","author":"Le Brech S","year":"2022","unstructured":"Le Brech S, Amat M, Temple D, Manteca X. Evaluation of two practical tools to assess cognitive impairment in aged dogs. Animals (Basel). 2022;12(24):3538. doi:10.3390\/ani12243538"},{"issue":"2","key":"ref15","series-title":"J Alzheimers Dis","first-page":"433","article-title":"Dogs with cognitive dysfunction as a spontaneous model for early Alzheimer\u2019s disease: a translational study of neuropathological and inflammatory markers","volume":"52","author":"Sch\u00fctt T","year":"2016","unstructured":"Sch\u00fctt T, Helboe L, Pedersen L\u00d8, Waldemar G, Berendt M, Pedersen JT. Dogs with cognitive dysfunction as a spontaneous model for early Alzheimer\u2019s disease: a translational study of neuropathological and inflammatory markers. J Alzheimers Dis. 2016;52(2):433-449. doi:10.3233\/JAD-151085"},{"issue":"1","key":"ref16","series-title":"Mol Neurodegener","first-page":"32","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure MA","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener. 2019;14(1):32. doi:10.1186\/s13024-019-0333-5"},{"key":"ref17","series-title":"Front Vet Sci","first-page":"551895","article-title":"Novel diagnostic tools for identifying cognitive impairment in dogs: behavior, biomarkers, and pathology","volume":"7","author":"Vikartovska Z","year":"2021","unstructured":"Vikartovska Z, Farbakova J, Smolek T,  Novel diagnostic tools for identifying cognitive impairment in dogs: behavior, biomarkers, and pathology (Published correction appears in Front Vet Sci. 2021;7:551895). Front Vet Sci. 2021;7:551895. doi:10.3389\/fvets.2020.551895"},{"issue":"2","key":"ref18","series-title":"Gerontology","first-page":"165","article-title":"Cognitive aging in dogs","volume":"64","author":"Chapagain D","year":"2018","unstructured":"Chapagain D, Range F, Huber L, Vir\u00e1nyi Z. Cognitive aging in dogs. Gerontology. 2018;64(2):165-171. doi:10.1159\/000481621"},{"issue":"1","key":"ref19","series-title":"Alzheimers Dement (N Y)","first-page":"e12050","article-title":"Alzheimer\u2019s disease drug development pipeline: 2020","volume":"6","author":"Cummings J","year":"2020","unstructured":"Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K. Alzheimer\u2019s disease drug development pipeline: 2020. Alzheimers Dement (N Y). 2020;6(1):e12050. doi:10.1002\/trc2.12050"},{"key":"ref20","series-title":"Front Vet Sci","first-page":"576262","article-title":"Veterinarians and one health in the fight against zoonoses such as COVID-19","volume":"7","author":"de Melo RT","year":"2020","unstructured":"de Melo RT, Rossi DA, Monteiro GP, Fernandez H. Veterinarians and one health in the fight against zoonoses such as COVID-19. Front Vet Sci. 2020;7:576262. doi:10.3389\/fvets.2020.576262"},{"issue":"9","key":"ref21","series-title":"Biochim Biophys Acta","first-page":"1384","article-title":"A canine model of human aging and Alzheimer\u2019s disease","volume":"1832","author":"Head E","year":"2013","unstructured":"Head E. A canine model of human aging and Alzheimer\u2019s disease. Biochim Biophys Acta. 2013;1832(9):1384-1389. doi:10.1016\/j.bbadis.2013.03.016"}],"container-title":["Journal of the American Veterinary Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/261\/11\/javma.23.02.0095.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/261\/11\/javma.23.02.0095.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/261\/11\/javma.23.02.0095.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T08:04:47Z","timestamp":1741334687000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/261\/11\/javma.23.02.0095.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":21,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.2460\/javma.23.02.0095","relation":{},"ISSN":["0003-1488"],"issn-type":[{"value":"0003-1488","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,1]]}}}